Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-25 @ 2:39 AM
NCT ID:
NCT07243834
Eligibility Criteria:
Inclusion Criteria:
1. Age \> 18 at randomisation
2. Men with histological confirmation of prostate adenocarcinoma who are receiving or planned to receive ADT with an LHRHa as part of their PCa treatment
3. If already started ADT, have received no more than eight weeks ADT at randomisation
4. Planned for radiotherapy
5. Assessed by clinical team to be safe to exercise and safe to enter the trial with no absolute contraindications to exercise as defined by clinical guidance
6. Able to use technological aspects of the intervention including access to MyMarsden and a device for video conferencing
7. Fluent in English and able to understand instructions
8. WHO performance status 0-2
9. Able to give written informed consent
Exclusion Criteria:
1. Men planned to receive an androgen receptor-targeted agent (ARTA) or chemotherapy
2. Absolute contraindication to exercise as defined by ACPICR standards. This includes:
* New symptoms of angina
* New or unstable heart failure
* Newly diagnosed diabetes that is not controlled
* New or untreated arrhythmias
* Resting tachycardia or new bradycardia (not linked to changes in medications)
* Symptomatic hypotension
* Uncontrolled hypertension (SBP ≥ 180mmHg or DBP≥ 100mmHg)
3. Unstable spinal bone metastasis or at high risk of a fracture
4. Musculoskeletal issue inhibiting exercise
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT07243834
Study Brief:
Protocol Section:
NCT07243834